These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 9001188)

  • 1. T-cell recognition of residue 158-176 in thyrotropin receptor confers risk for development of thyroid autoimmunity in siblings in a family with Graves' disease.
    Soliman M; Kaplan E; Guimaraes V; Yanagawa T; DeGroot LJ
    Thyroid; 1996 Dec; 6(6):545-51. PubMed ID: 9001188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T-cells recognize multiple epitopes in the human thyrotropin receptor extracellular domain.
    Soliman M; Kaplan E; Yanagawa T; Hidaka Y; Fisfalen ME; DeGroot LJ
    J Clin Endocrinol Metab; 1995 Mar; 80(3):905-14. PubMed ID: 7533773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does thyroidectomy, radioactive iodine therapy, or antithyroid drug treatment alter reactivity of patients' T cells to epitopes of thyrotropin receptor in autoimmune thyroid diseases?
    Soliman M; Kaplan E; Abdel-Latif A; Scherberg N; DeGroot LJ
    J Clin Endocrinol Metab; 1995 Aug; 80(8):2312-21. PubMed ID: 7543112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proliferative responses of peripheral blood mononuclear cells from patients with Graves' disease to synthetic peptides epitopes of human thyrotropin receptor.
    Okamoto Y; Yanagawa T; Fisfalen ME; DeGroot LJ
    Thyroid; 1994; 4(1):37-42. PubMed ID: 7519915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterogeneity in cellular and antibody responses against thyrotropin receptor in patients with Graves' disease detected using synthetic peptides.
    Fan JL; Desai RK; Seetharamaiah GS; Dallas JS; Wagle NM; Prabhakar BS
    J Autoimmun; 1993 Dec; 6(6):799-808. PubMed ID: 7512341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of major T cell epitopes on human thyroid stimulating hormone receptor by overriding immune heterogeneity in patients with Graves' disease.
    Martin A; Nakashima M; Zhou A; Aronson D; Werner AJ; Davies TF
    J Clin Endocrinol Metab; 1997 Oct; 82(10):3361-6. PubMed ID: 9329369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement of experimental Graves' disease by intranasal administration of a T cell epitope of the thyrotropin receptor.
    Arima T; Shimojo N; Yamaguchi K; Tomiita M; Kohn LD; Kohno Y
    Clin Immunol; 2008 Apr; 127(1):7-13. PubMed ID: 18234558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA-DR3 transgenic mice immunized with adenovirus encoding the thyrotropin receptor: T cell epitopes and functional analysis of the CD40 Graves' polymorphism.
    Pichurin P; Pham N; David CS; Rapoport B; McLachlan SM
    Thyroid; 2006 Dec; 16(12):1221-7. PubMed ID: 17199432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cepharanthine blocks TSH receptor peptide presentation by HLA-DR3: Therapeutic implications to Graves' disease.
    Li CW; Osman R; Menconi F; Concepcion E; Tomer Y
    J Autoimmun; 2020 Mar; 108():102402. PubMed ID: 31980336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct binding of thyrotropin receptor autoantibody to in vitro translated thyrotropin receptor: a comparison to radioreceptor assay and thyroid stimulating bioassay.
    Morgenthaler NG; Hodak K; Seissler J; Steinbrenner H; Pampel I; Gupta M; McGregor AM; Scherbaum WA; Banga JP
    Thyroid; 1999 May; 9(5):466-75. PubMed ID: 10365678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patterns of cellular immune responses to thyrocyte membrane antigens and specific immunoregulatory defects in autoimmune thyroid disease.
    O'Brien CJ; Macchia E; Cundy TF; Concetti R; McSorley CG; MacFarlane IG; Vento S; Eddleston AL
    J Clin Lab Immunol; 1990 Jul; 32(3):103-8. PubMed ID: 1966945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoimmunity of thyroid disease. With emphasis on Graves' disease.
    van Ouwerkerk BM; Krenning EP; Docter R; Benner R; Hennemann G
    Neth J Med; 1985; 28(1):32-9. PubMed ID: 2858065
    [No Abstract]   [Full Text] [Related]  

  • 13. The formation of thyrotropin receptor (TSHR) antibodies in a Graves' animal model requires the N-terminal segment of the TSHR extracellular domain.
    Kikuoka S; Shimojo N; Yamaguchi KI; Watanabe Y; Hoshioka A; Hirai A; Saito Y; Tahara K; Kohn LD; Maruyama N; Kohno Y; Niimi H
    Endocrinology; 1998 Apr; 139(4):1891-8. PubMed ID: 9528975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High frequency of T-cell lines responsive to immunodominant epitopes of thyrotropin receptor in healthy subjects.
    Molteni M; Zulian C; Scrofani S; Della Bella S; Bonara P; Kohn LD; Scorza R
    Thyroid; 1998 Mar; 8(3):241-7. PubMed ID: 9545111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cathepsin S is not crucial to TSHR processing and presentation in a murine model of Graves' disease.
    Kala M; Chen CR; McLachlan SM; Rapoport B; Aliesky H; Chapman HA
    Immunology; 2005 Dec; 116(4):532-40. PubMed ID: 16313367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of T lymphocyte subsets by synthetic TSH receptor peptides and recombinant glutamate decarboxylase in autoimmune thyroid disease and insulin-dependent diabetes.
    Mukuta T; Yoshikawa N; Arreaza G; Resetkova E; Leushner J; Song YH; Akasu F; Onaya T; Volpé R
    J Clin Endocrinol Metab; 1995 Apr; 80(4):1264-72. PubMed ID: 7714099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Failure to demonstrate cell-mediated immune responses to thyroid antigens in Graves' disease using in vitro assays of lymphokine-mediated migration inhibition.
    Ludgate ME; Ratanachaiyavong S; Weetman AP; Hall R; McGregor AM
    J Clin Endocrinol Metab; 1985 Jan; 60(1):98-102. PubMed ID: 3871093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Graves' disease in severe combined immunodeficient mice.
    Soliman M; Kaplan E; Straus F; Fisfalen ME; Hidaka Y; Guimaraes V; DeGroot LJ
    J Clin Endocrinol Metab; 1995 Oct; 80(10):2848-55. PubMed ID: 7559863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferon-gamma ELISPOT detecting reactivity of T cells to TSH receptor peptides in Graves' disease.
    Côté-Bigras S; Dionne A; Asselin-Mullen P; Leblicq C; Rottembourg D
    Clin Endocrinol (Oxf); 2014 Feb; 80(2):296-300. PubMed ID: 23734883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thyrotropin receptor epitopes and their relation to histocompatibility leukocyte antigen-DR molecules in Graves' disease.
    Inaba H; Martin W; De Groot AS; Qin S; De Groot LJ
    J Clin Endocrinol Metab; 2006 Jun; 91(6):2286-94. PubMed ID: 16595602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.